Secrin® M

Glimepiride and Metformin Hydrochloride
Oral Antidiabetic Drugs (Antidiabetic Preparations)

Indication:
Secrin® M is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes (T2DM)

Dosage & Administration:
The initial recommended dose of Glimepiride & Metformin combination tablet is Glimepiride 1 mg & Metformin Hydrochloride 500 mg one tablet once daily with breakfast or first main meal of the day. Starting dose for patients with inadequate glycemic control on Glimepiride or Metformin monotherapy is Secrin® M 1/500 tablet once daily, and gradually titrated after assessing the therapeutic response. The daily dose must be titrated in increments of 1 tablet. The maximum recommended dose per day is 8 mg Glimepiride and 2000 mg Metformin.

Preparation:
Secrin® M 1/500 XR Bilayer Tablet: Each box contains 28 bilayer tablets in blister pack.



  • Products By Trade Name

  • Products By Generic

  • Products By Therapeutic Class

  • Herbal & Nutraceuticals

  • AgroVet & Pesticides